Human | SFTPA1 | 653509 | surfactant protein A1 | Title:Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia|Association:Not Found|Conclusion:We propose that two separate SP-B gene polymorphisms have a phenotypic significance via |
Human | TIMP2 | 7077 | TIMP metallopeptidase inhibitor 2 | MMP and TIMP may be involved in the feto-neonatal development and may contribute to the pathogenesis of bronchopulmonary dysplasia and/or intraventricular hemorrhage in critically ill preterm neonates |
Human | TIMP1 | 7076 | TIMP metallopeptidase inhibitor 1 | MMP and TIMP may be involved in the feto-neonatal development and may contribute to the pathogenesis of bronchopulmonary dysplasia and/or intraventricular hemorrhage in critically ill preterm neonates MMP-9 level and TIMP-1 levels increased after birth but are not linked to bronchopulmonary dysplasia outcome; low MMP-2 level at birth is associated with the development of BPD |
Human | SFTPD | 6441 | surfactant protein D | Title:Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia|Association:Not Found|Conclusion:We propose that two separate SP-B gene polymorphisms have a phenotypic significance via |
Human | SFTPC | 6440 | surfactant protein C | Title:Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia|Association:Not Found|Conclusion:We propose that two separate SP-B gene polymorphisms have a phenotypic significance via |
Human | SFTPB | 6439 | surfactant protein B | Title:Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia|Association:Not Found|Conclusion:We propose that two separate SP-B gene polymorphisms have a phenotypic significance via |
Human | SFTPA2B | 6436 | | Title:Polymorphisms of surfactant protein A genes and the risk of bronchopulmonary dysplasia in preterm infants|Association:Not Found|Conclusion:In addition to previously established risk factors for BPD, 6A6 polymorphism for SP-A1 gene is an independent co-factor. We believe treatment of neonatal RDS should also include stratification according to genetic risk factors. |
Human | PRSS2 | 5645 | protease, serine, 2 (trypsin 2) | High levels of pulmonary trypsin-2 may be associated with the development of bronchopulmonary dysplasia in preterm infants |
Human | MMP16 | 4325 | matrix metallopeptidase 16 (membrane-inserted) | MMP16 polymorphisms appear to influence not only the pulmonary expression and function of MMP16 but also the risk of bronchopulmonary dysplasia |
Human | MMP9 | 4318 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | MMP and TIMP may be involved in the feto-neonatal development and may contribute to the pathogenesis of bronchopulmonary dysplasia and/or intraventricular hemorrhage in critically ill preterm neonates MMP-9 level and TIMP-1 levels increased after birth but are not linked to bronchopulmonary dysplasia outcome; low MMP-2 level at birth is associated with the development of BPD |
Human | MMP2 | 4313 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | MMP-9 level and TIMP-1 levels increased after birth but are not linked to bronchopulmonary dysplasia outcome; low MMP-2 level at birth is associated with the development of BPD MMP and TIMP may be involved in the feto-neonatal development and may contribute to the pathogenesis of bronchopulmonary dysplasia and/or intraventricular hemorrhage in critically ill preterm neonates |
Human | IL10 | 3586 | interleukin 10 | constitutive expression of IL-10 by lung inflammatory cells is associated with the risk for bronchopulmonary dysplasia |
Human | IL1RN | 3557 | interleukin 1 receptor antagonist | strong and early expression of interleukin-1 receptor antagonist(IL-1Ra) proves to be non-protective due to the robust expression of airway agonist interleukin-1beta seen by day 5 in premature infants who develop bronchopulmonary dysplasia (BPD) |
Human | IL1B | 3553 | interleukin 1, beta | strong and early expression of interleukin-1 receptor antagonist(IL-1Ra) proves to be non-protective due to the robust expression of airway agonist interleukin-1beta seen by day 5 in premature infants who develop bronchopulmonary dysplasia (BPD) |
Human | TNC | 3371 | tenascin C | tenascin-C is highly expressed in the walls of alveoli and bronchioli in respiratory distress syndrome and bronchopulmonary dysplasia |
Human | GSTA6P | 2942 | glutathione S-transferase alpha 6, pseudogene | The polymorphism of DSTAP1 are associated with the development of bronchopulmonary dysplasia |
Human | FGF7 | 2252 | fibroblast growth factor 7 | KGF may hold promise for the treatment of very premature neonates with bronchopulmonary dysplasia |
Human | F2RL1 | 2150 | coagulation factor II (thrombin) receptor-like 1 | strong expression of PAR(2) was detected in myofibroblasts of thickened and fibrotic alveolar walls in prolonged respiratory distress syndrome or bronchopulmonary dysplasia |
Human | ACE | 1636 | angiotensin I converting enzyme | The D allele of ACE is associated with an increased risk and severity of bronchopulmonary dysplasia |